Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tabassome Simon

Showing results (221-230 of 272) with videos related to

Pageof 28
Sort By:
Journal of the American Society of Nephrology : JASN|June 16, 2018
Transethnic, Genome-Wide Analysis Reveals Immune-Related Risk Alleles and Phenotypic Correlates in Pediatric Steroid-Sensitive Nephrotic SyndromeHanna Debiec, Claire Dossier, Eric Letouzé, et al.
Therapie|January 1, 2026
Accelerating recruitment in clinical trials: A strategic challengeDominique Deplanque, Ariane Galaup, Christine Trillou, et al.
The New England Journal of Medicine|September 3, 2019
Ticagrelor in Patients with Stable Coronary Disease and DiabetesP Gabriel Steg, Deepak L Bhatt, Tabassome Simon, et al.
Cell Metabolism|August 4, 2015
Indoleamine 2,3-Dioxygenase Fine-Tunes Immune Homeostasis in Atherosclerosis and Colitis through Repression of Interleukin-10 ProductionSarvenaz Metghalchi, Padmapriya Ponnuswamy, Tabassome Simon, et al.
International Journal of Cardiology|October 21, 2022
External applicability of the Effect of ticagrelor on Health Outcomes in diabEtes Mellitus patients Intervention Study (THEMIS) trial: An analysis of patients with diabetes and coronary artery disease in the REduction of Atherothrombosis for Continued Health (REACH) registryJeremie Abtan, Deepak L Bhatt, Yedid Elbez, et al.
Intensive Care Medicine|May 13, 2022
Comparison of 8 versus 15 days of antibiotic therapy for Pseudomonas aeruginosa ventilator-associated pneumonia in adults: a randomized, controlled, open-label trialAdrien Bouglé, Sophie Tuffet, Laura Federici, et al.
ESC Heart Failure|February 12, 2025
Burst steroid therapy and quality of life in patients with acute heart failure: Insights from the CORTAHF trialMatteo Pagnesi, Gad Cotter, Beth A Davison, et al.
Journal of the American College of Cardiology|June 11, 2021
Ending Gender Inequality in Cardiovascular Clinical Trial Leadership: JACC Review Topic of the WeekHarriette G C Van Spall, Anuradha Lala, Thomas F Deering, et al.
Journal of Cardiac Failure|October 1, 2024
The Effects of Burst Steroid Therapy on Short-term Decongestion in Acute Heart Failure Patients With Pro-inflammatory Activation: A Post Hoc Analysis of the CORTAHF Randomized, Open-label, Pilot TrialJan Biegus, Gad Cotter, Beth A Davison, et al.
Lancet (London, England)|September 6, 2019
Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trialDeepak L Bhatt, Philippe Gabriel Steg, Shamir R Mehta, et al.
Pageof 28

Showing results (221-230 of 272) with videos related to

Sort By:
Pageof 28
Journal of the American Society of Nephrology : JASN|June 16, 2018
Transethnic, Genome-Wide Analysis Reveals Immune-Related Risk Alleles and Phenotypic Correlates in Pediatric Steroid-Sensitive Nephrotic SyndromeHanna Debiec, Claire Dossier, Eric Letouzé, et al.
Therapie|January 1, 2026
Accelerating recruitment in clinical trials: A strategic challengeDominique Deplanque, Ariane Galaup, Christine Trillou, et al.
The New England Journal of Medicine|September 3, 2019
Ticagrelor in Patients with Stable Coronary Disease and DiabetesP Gabriel Steg, Deepak L Bhatt, Tabassome Simon, et al.
Cell Metabolism|August 4, 2015
Indoleamine 2,3-Dioxygenase Fine-Tunes Immune Homeostasis in Atherosclerosis and Colitis through Repression of Interleukin-10 ProductionSarvenaz Metghalchi, Padmapriya Ponnuswamy, Tabassome Simon, et al.
International Journal of Cardiology|October 21, 2022
External applicability of the Effect of ticagrelor on Health Outcomes in diabEtes Mellitus patients Intervention Study (THEMIS) trial: An analysis of patients with diabetes and coronary artery disease in the REduction of Atherothrombosis for Continued Health (REACH) registryJeremie Abtan, Deepak L Bhatt, Yedid Elbez, et al.
Intensive Care Medicine|May 13, 2022
Comparison of 8 versus 15 days of antibiotic therapy for Pseudomonas aeruginosa ventilator-associated pneumonia in adults: a randomized, controlled, open-label trialAdrien Bouglé, Sophie Tuffet, Laura Federici, et al.
ESC Heart Failure|February 12, 2025
Burst steroid therapy and quality of life in patients with acute heart failure: Insights from the CORTAHF trialMatteo Pagnesi, Gad Cotter, Beth A Davison, et al.
Journal of the American College of Cardiology|June 11, 2021
Ending Gender Inequality in Cardiovascular Clinical Trial Leadership: JACC Review Topic of the WeekHarriette G C Van Spall, Anuradha Lala, Thomas F Deering, et al.
Journal of Cardiac Failure|October 1, 2024
The Effects of Burst Steroid Therapy on Short-term Decongestion in Acute Heart Failure Patients With Pro-inflammatory Activation: A Post Hoc Analysis of the CORTAHF Randomized, Open-label, Pilot TrialJan Biegus, Gad Cotter, Beth A Davison, et al.
Lancet (London, England)|September 6, 2019
Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trialDeepak L Bhatt, Philippe Gabriel Steg, Shamir R Mehta, et al.
Pageof 28